NCT02270567
RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide
Enrolling by Invitation
Not specifiedAges 18+ObservationalWren Laboratories LLC
~400 participants
Updated 2025-11-13 on ClinicalTrials.gov
What's tested:NETest
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Tumor-related recurrence or progression
Measured over 5 years
+2 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesConnecticut1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Gastroenteropancreatic neuroendocrine tumor
Bronchopulmonary neuroendocrine tumor
Gastroenteropancreatic neuroendocrine carcinoma
Pre- and post-surgical patients
Watch \& Wait/no treatment
Treatment including somatostatin analogues, PRRT, targeted therapies.
Patient provides informed consent
Exclusion
N/A
What this trial measures
- Tumor-related recurrence or progression5 years
Image-based identification of recurrent or progressive tumor disease
- Tumor-related diagnosis1 year
Histological confirmation of neuroendocrine tumor
- Tumor-related mortality10 years
Survival from disease